Health ❯ Healthcare ❯ Clinical Trials

Weight Management

Patient Outcomes Obesity Efficacy of Weight-loss Drugs SURMOUNT-1 Study Obesity Treatments Orforglipron GLP-1 Agonists

CHMP Recommends Adding Oral Wegovy Tablets to EU Approval

European Commission approval would create the first oral GLP‑1 for adult weight management with pricing left to EU Member States.

Lilly’s Daily Obesity Pill Sustains Weight Loss After Switch From Wegovy or Zepbound

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves